A randomized controlled trial of an Internet-based psychological treatment for disordered gambling

Not Applicable

• Conditions: Gambling disorder; Mental and Behavioural Disorders

• Registration Number: ISRCTN38692394
• Lead Sponsor: Sahlgrenska University Hospital

Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38146277/ (added 27/12/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-04-25
• Last Update Posted: 8 January 2024
• Study Completion: 2025-01-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 71

Inclusion Criteria

Eligible participants are all patients that are treated at the Unit for gambling addiction and screen health, Sahlgrenska University, Gothenburg, Sweden, and that meet the following inclusion criteria:
1. 18-75 years old
2. Any gender
3. Meet DSM-5 criteria for Gambling Disorder
4. Have access to the internet
5. Are able to read and write Swedish fluently

Exclusion Criteria

Participants will be excluded if they:
1. Have somatic or psychiatric conditions that contraindicate treatment or severely hinders treatment participation (e.g. ongoing psychotic, manic or hypomanic episode, or a developmental disorder causing severe disability)
2. Have an increased risk of suicide (based on assessment during the diagnostic interview)
3. Are currently in another ongoing psychological treatment with similar content as the one offered in this study
4. Have started medication for a psychiatric condition during the last three weeks
5. Plan to start another treatment (psychotherapy or medication) for their gambling disorder during the course of the 8-week treatment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measure as of 07/12/2022:<br>Gambling-related behaviour measured using the NODS: The NORC Diagnostic Screen for Gambling Problems (NODS) (Wickwire et al., 2008). NODS will be adapted to a 14-day version. It will be administered at assessment, baseline, every 14 days of treatment, at treatment end and at follow-ups at 6, 12 and 24 months post-treatment.<br><br>Previous primary outcome measure:<br>Gambling-related behaviour measured using the NODS: The NORC Diagnostic Screen for Gambling Problems (NODS) (Wickwire et al., 2008) and The Time Line Follow Back (TLFB), adapted to measure pathological gambling (G-TLFB) (Hodgins & Makarchuk 2003). NODS will be adapted to a 14-day version. It will be administered at assessment, baseline, every 14 days of treatment, at treatment end and at follow-ups at 6, 12 and 24 months post-treatment. The GTLFB will be administered at baseline, every 7 days during treatment, at treatment end and at follow-ups at 6, 12 and 24 months post-treatment.